funder-graph

FundersWIThe American Society of Gene & Cell Therapy › 2022

Grants paid by The American Society of Gene & Cell Therapy, tax year 2022

EIN 91-1766321 · Waukesha, WI · Form 990, Schedule I · NTEE H20

In tax year 2022, The American Society of Gene & Cell Therapy (EIN 91-1766321) reported 7 grants paid totaling $800,000. Dataset version 2026.09.0, built 2026-09-03.

2020202220232024

Every grant, 2022

Grants reported by The American Society of Gene & Cell Therapy for tax year 2022
Tax yearRecipientMatchAmountTypePurposeSource filing
2022Massachusetts Gen Hospital Boston, MAA$200,000paidCAREER DEVELOPMENT202343139349301974
2022Beckman Research Institute of the City of Hope Duarte, CAU$100,000paidCAREER DEVELOPMENT202343139349301974
2022University of North Carolina at Chapel Hill Atlanta, GAA$100,000paidCAREER DEVELOPMENT202343139349301974
2022Stanford University Los Angeles, CAA$100,000paidCAREER DEVELOPMENT202343139349301974
2022Baylor College of Medicine Houston, TXA$100,000paidCAREER DEVELOPMENT202343139349301974
2022Augusta University Research Institute Inc Atlanta, GAA$100,000paidDEI UNDERREPRESENTED AWARD202343139349301974
2022Medical University of South Carolina Charleston, SCA$100,000paidCAREER DEVELOPMENT202343139349301974

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.